261 related articles for article (PubMed ID: 31273418)
1. Poorly differentiated thyroid carcinoma : An underdiagnosed entity.
Dettmer MS; Schmitt A; Komminoth P; Perren A
Pathologe; 2020 Jun; 41(Suppl 1):1-8. PubMed ID: 31273418
[TBL] [Abstract][Full Text] [Related]
2. [Poorly differentiated thyroid carcinoma : An underdiagnosed entity. German version].
Dettmer MS; Schmitt A; Komminoth P; Perren A
Pathologe; 2019 May; 40(3):227-234. PubMed ID: 31093689
[TBL] [Abstract][Full Text] [Related]
3. Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma.
Xu B; Ghossein R
Endocr Pathol; 2016 Sep; 27(3):205-12. PubMed ID: 27372303
[TBL] [Abstract][Full Text] [Related]
4. High-Grade Non-Anaplastic Thyroid Carcinomas of Follicular Cell Origin: A Review of Poorly Differentiated and High-Grade Differentiated Carcinomas.
Cracolici V; Cipriani NA
Endocr Pathol; 2023 Mar; 34(1):34-47. PubMed ID: 36692728
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle deregulation and TP53 and RAS mutations are major events in poorly differentiated and undifferentiated thyroid carcinomas.
Pita JM; Figueiredo IF; Moura MM; Leite V; Cavaco BM
J Clin Endocrinol Metab; 2014 Mar; 99(3):E497-507. PubMed ID: 24423316
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas.
Nikiforov YE
Endocr Pathol; 2004; 15(4):319-27. PubMed ID: 15681856
[TBL] [Abstract][Full Text] [Related]
7. Significance of oncocytic features in poorly differentiated thyroid carcinoma - a bi-institutional experience.
Xu B; Lubin DJ; Dogan S; Ghossein RA; Viswanathan K
Virchows Arch; 2023 Mar; 482(3):479-491. PubMed ID: 36346459
[TBL] [Abstract][Full Text] [Related]
8. Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions.
Albores-Saavedra J; Hernandez M; Sanchez-Sosa S; Simpson K; Angeles A; Henson DE
Am J Surg Pathol; 2007 May; 31(5):729-36. PubMed ID: 17460457
[TBL] [Abstract][Full Text] [Related]
9. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas.
Sakamoto A; Kasai N; Sugano H
Cancer; 1983 Nov; 52(10):1849-55. PubMed ID: 6313176
[TBL] [Abstract][Full Text] [Related]
10. Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed?
Dettmer M; Schmitt A; Steinert H; Haldemann A; Meili A; Moch H; Komminoth P; Perren A
Am J Surg Pathol; 2011 Dec; 35(12):1866-72. PubMed ID: 21989341
[TBL] [Abstract][Full Text] [Related]
11. The Oncocytic Variant of Poorly Differentiated Thyroid Carcinoma Shows a Specific Immune-Related Gene Expression Profile.
Metovic J; Vignale C; Annaratone L; Osella-Abate S; Maletta F; Rapa I; Cabutti F; Patriarca S; Gallo M; Nikiforov YE; Volante M; Papotti M
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32936917
[TBL] [Abstract][Full Text] [Related]
12. Poorly differentiated thyroid cancer.
Patel KN; Shaha AR
Curr Opin Otolaryngol Head Neck Surg; 2014 Apr; 22(2):121-6. PubMed ID: 24492853
[TBL] [Abstract][Full Text] [Related]
13. Poorly differentiated thyroid carcinoma.
Xu B; Ghossein R
Semin Diagn Pathol; 2020 Sep; 37(5):243-247. PubMed ID: 32360274
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation.
Amacher AM; Goyal B; Lewis JS; El-Mofty SK; Chernock RD
Am J Surg Pathol; 2015 Feb; 39(2):260-5. PubMed ID: 25321328
[TBL] [Abstract][Full Text] [Related]
15. Search for new genetic biomarkers in poorly differentiated and anaplastic thyroid carcinomas using next generation sequencing.
Sykorova V; Dvorakova S; Vcelak J; Vaclavikova E; Halkova T; Kodetova D; Lastuvka P; Betka J; Vlcek P; Reboun M; Katra R; Bendlova B
Anticancer Res; 2015 Apr; 35(4):2029-36. PubMed ID: 25862857
[TBL] [Abstract][Full Text] [Related]
16. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
[TBL] [Abstract][Full Text] [Related]
17. Differentiated thyroid carcinoma, intermediate type: a new tumor entity with features of follicular and parafollicular cell carcinoma.
Ljungberg O; Bondeson L; Bondeson AG
Hum Pathol; 1984 Mar; 15(3):218-28. PubMed ID: 6141993
[TBL] [Abstract][Full Text] [Related]
18. Histological and functional correlation of thyroid carcinoma by immunohistochemistry.
Prathiba D; Rao KR; Madhavan M
Indian J Pathol Microbiol; 1990 Jan; 33(1):35-40. PubMed ID: 2394474
[TBL] [Abstract][Full Text] [Related]
19. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
20. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
Nikiforova MN; Kimura ET; Gandhi M; Biddinger PW; Knauf JA; Basolo F; Zhu Z; Giannini R; Salvatore G; Fusco A; Santoro M; Fagin JA; Nikiforov YE
J Clin Endocrinol Metab; 2003 Nov; 88(11):5399-404. PubMed ID: 14602780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
